Found: 14
Select item for more details and to access through your institution.
Clinical Potential of Hypoxia Inducible Factors Prolyl Hydroxylase Inhibitors in Treating Nonanemic Diseases.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.837249
- By:
- Publication type:
- Article
LONP1 targets HMGCS2 to protect mitochondrial function and attenuate chronic kidney disease.
- Published in:
- EMBO Molecular Medicine, 2023, v. 15, n. 2, p. 1, doi. 10.15252/emmm.202216581
- By:
- Publication type:
- Article
Chemical dampening of Ly6C<sup>hi</sup> monocytes in the periphery produces anti-depressant effects in mice.
- Published in:
- Scientific Reports, 2016, p. 19406, doi. 10.1038/srep19406
- By:
- Publication type:
- Article
Farnesoid X receptor activation promotes cell proliferation via PDK4-controlled metabolic reprogramming.
- Published in:
- Scientific Reports, 2016, p. 18751, doi. 10.1038/srep18751
- By:
- Publication type:
- Article
UDP-Glucuronosyltransferase 1A Compromises Intracellular Accumulation and Anti-Cancer Effect of Tanshinone IIA in Human Colon Cancer Cells.
- Published in:
- PLoS ONE, 2013, v. 8, n. 11, p. 1, doi. 10.1371/journal.pone.0079172
- By:
- Publication type:
- Article
An NQO1-Initiated and p53-Independent Apoptotic Pathway Determines the Anti-Tumor Effect of Tanshinone IIA against Non-Small Cell Lung Cancer.
- Published in:
- PLoS ONE, 2012, v. 7, n. 7, p. 1, doi. 10.1371/journal.pone.0042138
- By:
- Publication type:
- Article
In Silico and In Vivo Pharmacokinetic Evaluation of 84-B10, a Novel Drug Candidate against Acute Kidney Injury and Chronic Kidney Disease.
- Published in:
- Molecules, 2024, v. 29, n. 1, p. 159, doi. 10.3390/molecules29010159
- By:
- Publication type:
- Article
From Physiology to Pathology: The Role of Mitochondria in Acute Kidney Injuries and Chronic Kidney Diseases.
- Published in:
- Kidney Diseases, 2023, v. 9, n. 5, p. 342, doi. 10.1159/000530485
- By:
- Publication type:
- Article
TP53RK Drives the Progression of Chronic Kidney Disease by Phosphorylating Birc5.
- Published in:
- Advanced Science, 2023, v. 10, n. 25, p. 1, doi. 10.1002/advs.202301753
- By:
- Publication type:
- Article
Rotenone Protects Against Acetaminophen-Induced Kidney Injury by Attenuating Oxidative Stress and Inflammation.
- Published in:
- Kidney & Blood Pressure Research, 2018, v. 43, n. 4, p. 1297, doi. 10.1159/000492589
- By:
- Publication type:
- Article
Insignificant Difference in Biocompatibility of Regenerated Silk Fibroin Prepared with Ternary Reagent Compared with Regenerated Silk Fibroin Prepared with Lithium Bromide.
- Published in:
- Polymers (20734360), 2022, v. 14, n. 18, p. N.PAG, doi. 10.3390/polym14183903
- By:
- Publication type:
- Article
Anti-anemia drug FG4592 retards the AKI-to-CKD transition by improving vascular regeneration and antioxidative capability.
- Published in:
- Clinical Science, 2021, v. 135, n. 14, p. 1707, doi. 10.1042/CS20210100
- By:
- Publication type:
- Article
Rotenone protects against β-cell apoptosis and attenuates type 1 diabetes mellitus.
- Published in:
- Apoptosis, 2019, v. 24, n. 11/12, p. 879, doi. 10.1007/s10495-019-01566-4
- By:
- Publication type:
- Article
Influence of PM<sub>1</sub> exposure on total and cause-specific respiratory diseases: a systematic review and meta-analysis.
- Published in:
- Environmental Science & Pollution Research, 2022, v. 29, n. 10, p. 15117, doi. 10.1007/s11356-021-16536-0
- By:
- Publication type:
- Article